Evidence map›Paper›PMID 37954878›Full record

ArticleFrontiers in neuroscience2023

Regional sex differences in neurochemical profiles of healthy mice measured by magnetic resonance spectroscopy at 9.4 tesla.

Ivan Tkáč, Tiankai Xie, Nitya Shah, Sarah Larson, Janet M Dubinsky, Rocio Gomez-Pastor, Hayley S McLoughlin, Harry T Orr, Lynn E Eberly, Gülin Öz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ivan TkáčCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, United States.
Tiankai XieDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, United States.
Nitya ShahDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, United States.
Sarah LarsonCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, United States.
Janet M DubinskyDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Rocio Gomez-PastorDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Hayley S McLoughlinDepartment of Neurology, University of Michigan, Ann Arbor, MI, United States.
Harry T OrrDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States.
Lynn E EberlyCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, United States.
Gülin ÖzCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, United States.
University of Minnesota · USResonance Research (United States) · USUniversity of Michigan · US

Funding

TRD4 - Ultrahigh Field Engineering and SafetyP41EB027061 · NIBIB · UNIVERSITY OF MINNESOTA · PI Mehmet Akcakaya · 2019 to 2026
$11.7M
Molecular Genetics of the SCA1 LocusR37NS022920 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ORR, HARRY T. · 2004 to 2017
$5.9M
Institutional Center Cores for Advanced NeuroimagingP30NS076408 · NINDS · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2012 to 2020
$4.2M
Molecular mechanisms of synaptic dysfunction and cognitive decline in Huntington's diseaseR01NS110694 · NINDS · UNIVERSITY OF MINNESOTA · PI Rocio Gomez-Pastor · 2020 to 2026
$3.1M
Nonneuronal Mechanisms of Polyglutamine NeurodegenerationR01NS122751 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCLOUGHLIN, HAYLEY S · 2021 to 2025
$2.2M
Preclinical Development of Antisense Oligonucleotide Therapy for Spinocerebellar Ataxia Type 3U01NS106670 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCLOUGHLIN, HAYLEY SARAH, PAULSON, HENRY L · 2018 to 2021
$2.1M
Defining Biomarkers for Spinocerebellar Ataxia Type 3R21NS111154 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCLOUGHLIN, HAYLEY SARAH, OZ, GULIN · 2019 to 2019
$435k
NIBIB NIH HHS P41 EB027061NINDS NIH HHS P30 NS076408NINDS NIH HHS R01 NS110694NINDS NIH HHS R01 NS122751NINDS NIH HHS R21 NS111154NINDS NIH HHS R37 NS022920NINDS NIH HHS U01 NS106670
6 · The paper itself

Abstract

Objective: To determine sex differences in the neurochemical concentrations measured by Methods: Results: Concentrations of taurine, total creatine (creatine + phosphocreatine), ascorbate, glucose and glutamate were consistently higher in male vs. female mice in most brain regions. Striatum was an exception with similar total creatine in male and female mice. The sex difference pattern in the hypothalamus was notably different from other regions. Interaction between sex and age was significant for total creatine and taurine in the cerebellum and hippocampus. Conclusion: Sex differences in regional neurochemical levels are small but significant and age-dependent, with consistent male-female differences across most brain regions. The neuroendocrine region hypothalamus displays a different pattern of sex differences in neurochemical levels. Differences in energy metabolism and cellular density may underlie the differences, with higher metabolic rates in females and higher osmoregulatory and antioxidant capacity in males.

Indexed as

ascorbateglucoseglutamatemetabolitetaurinetotal creatine

Identifiers

PMID37954878
PMCPMC10634209
OpenAlexW4388266554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.